Cardiotoxicity of chemicals: Current regulatory guidelines, knowledge gaps, and needs

Main Article Content

Alexandra Schaffert, Sivakumar Murugadoss, Birgit Mertens, Martin Paparella
[show affiliations]

Article Details

How to Cite
Schaffert, A., Murugadoss, S., Mertens, B. . and Paparella, M. (2023) “Cardiotoxicity of chemicals: Current regulatory guidelines, knowledge gaps, and needs”, ALTEX - Alternatives to animal experimentation, 40(2), pp. 337–340. doi: 10.14573/altex.2301121.
Author Biography

Birgit Mertens, Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium; Department of Pharmaceutical Sciences, Universiteit Antwerpen, Wilrijk, Belgium




Bopp, S. K., Kienzler, A., Richarz, A. N. et al. (2019). Regulatory assessment and risk management of chemical mixtures: Challenges and ways forward. Crit Rev Toxicol 49, 174-189. doi:10.1080/10408444.2019.1579169

Burnett, S. D., Blanchette, A. D., Chiu, W. A. et al. (2021). Cardiotoxicity hazard and risk characterization of ToxCast chemicals using human induced pluripotent stem cell-derived cardiomyocytes from multiple donors. Chem Res Toxicol 34, 2110-2124. doi:10.1021/acs.chemrestox.1c00203

Daley, M. C., Mende, U., Choi, B. R. et al. (2023). Beyond pharmaceuticals: Fit-for-purpose new approach methodologies for environmental cardiotoxicity testing. ALTEX 40, 103-116. doi:10.14573/altex.2109131

ECHA (2017). Guidance on the Biocidal Products Regulation: Volume III Human Health – Assessment & Evaluation (Parts B+C).

EU (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006. (accessed 01.09.2022)

EU (2009). Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009. (accessed 01.09.2022)

EU (2012). Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012. (accessed 01.09.2022)

Kemikalieinspektionen (2021). PM 8/21: Improving the regulatory assessment of combination effects: Steps towards implementing the mixture assessment factor (MAF) in chemical regulation. (accessed 25.11.2022)

Krishna, S., Berridge, B. and Kleinstreuer, N. (2021). High-throughput screening to identify chemical cardiotoxic potential. Chem Res Toxicol 34, 566-583. doi:10.1021/acs.chemrestox.0c00382

OECD (2017). Chemical Safety Assessment Workflow Based on Exposure Considerations and Non-Animal Methods. Series on Testing and Assessment, No. 275. OECD Publishing, Paris.

OECD (2022). OECD Test Guidelines for Chemicals. (accessed 05.07.2022)

Paparella, M., Colacci, A. and Jacobs, M. N. (2017). Uncertainties of testing methods: What do we (want to) know about carcinogenicity? ALTEX 34, 235-252. doi:10.14573/altex.1608281

Paparella, M., Bennekou, S. H. and Bal-Price, A. (2020). An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches. Reprod Toxicol 96, 327-336. doi:10.1016/j.reprotox.2020.08.002

WHO – World Health Organization (2018). Guidance Document on Evaluating and Expressing Uncertainty in Hazard Characterization The International Programme on Chemical Safety.

Most read articles by the same author(s)

1 2 > >>